Stay updated on CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Sign up to get notified when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.

Latest updates to the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page
- Check6 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the RGX-121 gene therapy study in children with MPS II, including participation details, study design, and measured outcomes.SummaryDifference58%

- Check13 days agoChange DetectedThe site footer revision label changed from v3.7.2 to v3.8.0. The study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA site-wide NIH banner announces a terminology transition and links to updates and FAQs. The footer revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1, while the study page still displays a 403 error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study content with a minimal header and a Home link. This indicates access to the study record is blocked rather than updated with new study information.SummaryDifference20%

- Check62 days agoChange DetectedRevision metadata on the study page was updated from v3.6.6 to v3.7.0. This indicates a software update to the page rendering or underlying platform rather than changes to the study content.SummaryDifference0.1%

Stay in the know with updates to CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.